Scientists at Heidelberg University in Germany believe they have identified a hidden mechanism deep inside the Alzheimer’s-affected brain that may be one of the primary drivers of the disease, and they have found a compound that can switch it off. The research centers on two proteins that under normal conditions operate independently and serve healthy functions in the brain. But in Alzheimer’s, the two proteins begin pairing in a destructive way that researchers now call a death complex, a combination that damages and kills nerve cells, causes memory loss, and also appears to drive the buildup of amyloid deposits, the protein accumulation long considered one of the hallmarks of the disease. Levels of this harmful pairing were found to be significantly higher in Alzheimer’s mice than in healthy ones, pointing directly at the complex as a meaningful target.
The team developed and tested a compound called FP802 designed to break apart this toxic protein bond at the precise point where the two proteins connect. In mouse experiments, the treatment markedly slowed disease progression, protected synapses from structural damage, preserved the function of the tiny cellular engines that power brain cells, and kept learning and memory abilities largely intact. Perhaps most surprisingly, treated mice also showed a significant drop in amyloid buildup, suggesting the compound does not just address downstream damage but also reduces one of the disease’s most recognized markers. The lead researcher noted that FP802 has also shown protective effects in models of ALS, raising the possibility that this same mechanism plays a role in multiple neurodegenerative diseases. The research team cautions that human clinical trials remain years away and that extensive pharmacological testing is still needed, but the findings, published in Molecular Psychiatry, represent a genuinely new angle of attack on a disease that has resisted effective treatment for decades.
Source: https://www.sciencedaily.com/releases/2026/03/260323005526.htm
